Metabolism of R- and S-Warfarin by CYP2C19 into Four Hydroxywarfarins
- 1 March 2013
- journal article
- Published by Bentham Science Publishers Ltd. in Drug Metabolism Letters
- Vol. 6 (3) , 157-164
Abstract
Coumadin (R/S-warfarin) is a highly efficacious and widely used anticoagulant; however, its highly variable metabolism remains an important contributor to uncertainties in therapeutic responses. Pharmacogenetic studies report conflicting findings on the clinical relevance of CYP2C19. A resolution to this controversy is impeded by a lack of detail on the potential role of CYP2C19 in warfarin metabolism. Consequently, we assessed the efficiency of CYP2C19 metabolism of R- and S-warfarin and explored possible contributions in the liver using in vitro methods. Recombinant CYP2C19 metabolized R- and S-warfarin mainly to 6-, 7-, and 8-hydroxywarfarin, while 4'-hydroxywarfarin was a minor metabolite. Overall R-warfarin metabolism was slightly more efficient than that for S-warfarin. Metabolic pathways that produce R-6-, 7-, and 8-hydroxywarfarin in human liver microsomal reactions correlated strongly with CYP2C19 Smephenytoin hydroxylase activity. Similarly, CYP1A2 activity toward phenacetin correlated with formation of R-6 and 7- hydroxywarfarin such that R-8-hydroxywarfarin seems unique to CYP2C19 and possibly a biomarker. In following, CYP2C19 likely impacts R-warfarin metabolism and patient response to therapy. Intriguingly, CYP2C19 may contribute to S-warfarin metabolism in patients, especially when CYP2C9 activity is compromised due to drug interactions or genetic polymorphisms.Keywords
This publication has 29 references indexed in Scilit:
- VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patientsClinical Pharmacology & Therapeutics, 2006
- The beginning of the end of warfarin?Medical Journal of Australia, 2004
- Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous ThromboembolismAnnals of Internal Medicine, 2003
- Care of Patients Receiving Long-Term Anticoagulant TherapyNew England Journal of Medicine, 2003
- In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.2001
- Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.Molecular Pharmacology, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.Journal of Biological Chemistry, 1985
- Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in manClinical Pharmacology & Therapeutics, 1974
- Effect of cigarette smoking on phenacetin metabolismClinical Pharmacology & Therapeutics, 1974